Skip to main content
. 2019 Oct 31;31(6):673–677. doi: 10.5021/ad.2019.31.6.673

Table 1. WHO 2016 Revised Diagnostic Criteria for chronic neutrophilic leukemia.

1. Peripheral blood WBC ≥25×109/L
 Segmented neutrophils plus band forms ≥80% of WBC
 Neutrophil precursors (promyelocytes, myelocytes, and metamyelocytes) <10% of WBC
 Myeloblasts rarely observed
 Monocyte count <1×109/L
 No dysgranulopoiesis
2. Hypercellular bone marrow
 Neutrophil granulocytes increased in percentage and number
 Normal neutrophil maturation
 Myeloblasts <5% of nucleated cells
3. Not meeting WHO criteria for BCR-ABL+ CML, PV, ET, or PMF
4. No rearrangement of PDGFRA, PDGFRB, or FGFR1, or PCM1-JAK2
5. Presence of CSF3RT618I or other activating CSF3R mutation
 In the absence of a CSFR3R mutation, persistent neutrophilia (at least 3 months), splenomegaly, and no identifiable cause of reactive neutrophilia including absence of a plasma cell neoplasm or, if present, demonstration of clonality of myeloid cells by cytogenetic or molecular studies

WHO: World Health Organization, WBC: white blood cells, CML: chronic myeloid leukemia, PV: polycythemia vera, ET: essential thrombocythemia, PMF: primary myelofibrosis.